. 2018 Feb 3;59(2):207–215. doi: 10.1093/jrr/rrx100

Table 3.

The standard conanical coefficients for canonical variates among these three variable sets for prostate cancer patients

	Complexity vs quality	Complexity vs γ(2D/3D)		Plan quality vs γ(2D/3D)	Complexity vs γ(IV)		Plan quality vs γ(IV)
	Canonical variate 1	Canonical variate 1	Canonical variate 2	Canonical variate1	Canonical variate1	Canonical variate 2	Canonical variate 1
Complexity parameter
MU/CP	−0.49	−0.15	−1.57		−1.69	0.53
%MU/CP < 3	−0.02	0.28	−0.68		−0.46	0.23
SA(cm²)/CP	0.34	−1.14	−2.85		1.63	2.04
%SA < 5 × 5 cm²	0.18	0.19	−0.85		0.87	0.66
MCSv/Beam(Arc)	0.26	0.66	0.17		−0.44	−0.13
LT (mm/Arc)	−0.28	0.68	−0.79		0.98	1.30
PTV volume	−0.006	0.39	1.38		−0.99	−1.39
Plan quality
GTVV_95%	−0.51			−0.77			−0.26
PTVV_95%	0.42			−0.1			−0.44
GTVHI	3.70			−4.33			−8.08
PTVHI	0.42			−0.54			−0.59
CI	6.28			−6.05			−12.86
CN	−5.81			5.54			11.96
Rectum D_mean	0.31			0.09			−0.64
Rectum V₅₀	−0.50			0.1			0.86
Bladder D_mean	−0.44			0.07			0.48
Bladder D₄₀	0.42			0.03			−0.66
Rfemoral D₃	0.83			−0.61			−0.38
Lfemoral D₃	−3.20			−0.04			0.81
Deliverability (2D/3D gamma indices)				Individual volume-based 3D gamma indices γ(IV)
2D 4%/4 mm		0.86	0.81	0.69	0.009	−0.95	−0.49	γGTV
2D 3%/3 mm		−0.80	−0.86	−0.07	0.37	−0.56	−1.16	γCTV
2D 2%/2 mm		−0.24	−0.11	−1.14	0.35	0.58	0.84	γPTV
3D 4%/4 mm		−0.48	−0.30	0.03	0.55	0.18	−0.52	γRectum
3D 3%/3 mm		0.11	1.51	0.26	0.69	0.11	−0.10	γlfemoral
3D 2%/2 mm		−0.25	−0.47	0.56	0.19	0.11	0.32	γr femoral
					−0.82	0.18	0.39	γbladder

%MU/CP < 3 = the proportion of MU/CP less than 3, %SA < 5 × 5 cm² = the proportion of SA less than 5 × 5 cm², GTVV_95% = the percentage volume of the GTV covered by the the 95% prescription isodose line, PTVV_95% = the percentage volume of the PTV covered by the 95% prescription isodose line, GTVHI = the HI of the GTV, PTVHI = the HI of the PTV, lfemoral = left femoral head, rfemoral = right femoral head.